Soft Bioelectronics for Heart Monitoring,ACS Sensors

当前位置： X-MOL 学术 › ACS Sens. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Soft Bioelectronics for Heart Monitoring
ACS Sensors ( IF 8.2 ) Pub Date : 2024-09-06 , DOI: 10.1021/acssensors.4c00442
Hadi Mirzajani ₁ , Michael Kraft _{2,

3}

Affiliation

Cardiovascular diseases (CVDs) are a predominant global health concern, accounting for over 17.9 million deaths in 2019, representing approximately 32% of all global fatalities. In North America and Europe, over a million adults undergo cardiac surgeries annually. Despite the benefits, such surgeries pose risks and require precise postsurgery monitoring. However, during the postdischarge period, where monitoring infrastructures are limited, continuous monitoring of vital signals is hindered. In this area, the introduction of implantable electronics is altering medical practices by enabling real-time and out-of-hospital monitoring of physiological signals and biological information postsurgery. The multimodal implantable bioelectronic platforms have the capability of continuous heart sensing and stimulation, in both postsurgery and out-of-hospital settings. Furthermore, with the emergence of machine learning algorithms into healthcare devices, next-generation implantables will benefit artificial intelligence (AI) and connectivity with skin-interfaced electronics to provide more precise and user-specific results. This Review outlines recent advancements in implantable bioelectronics and their utilization in cardiovascular health monitoring, highlighting their transformative deployment in sensing and stimulation to the heart toward reaching truly personalized healthcare platforms compatible with the Sustainable Development Goal 3.4 of the WHO 2030 observatory roadmap. This Review also discusses the challenges and future prospects of these devices.

中文翻译：

用于心脏监测的软生物电子学

心血管疾病 (CVD) 是全球主要的健康问题，2019 年导致超过 1790 万人死亡，约占全球死亡人数的 32%。在北美和欧洲，每年有超过一百万成年人接受心脏手术。尽管有这些好处，但此类手术也会带来风险，并且需要精确的术后监测。然而，在出院后期间，监测基础设施有限，对生命信号的连续监测受到阻碍。在这一领域，植入式电子设备的引入正在改变医疗实践，实现对术后生理信号和生物信息的实时和院外监测。多模式植入式生物电子平台具有在术后和院外环境中连续心脏传感和刺激的能力。此外，随着机器学习算法在医疗保健设备中的出现，下一代植入设备将受益于人工智能 (AI) 和与皮肤接口电子设备的连接，以提供更精确和针对用户的结果。本综述概述了植入式生物电子学的最新进展及其在心血管健康监测中的应用，强调了它们在心脏传感和刺激方面的变革性部署，以实现与世界卫生组织 2030 年观察站路线图可持续发展目标 3.4 相兼容的真正个性化医疗保健平台。本评论还讨论了这些设备的挑战和未来前景。

更新日期：2024-09-06

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南